In her role as vice president, Marie oversees the internal and external delivery and device innovation programs at Lilly’s Indianapolis site and the Cambridge Innovation Center, with a focus on creating critical paths to disruptive innovation in pharma drug delivery across diabetes, autoimmune conditions, CNS and oncology. Prior to joining Lilly, Marie served as Principal of Schiller Advisors and Partner Emeritus at Health Advances where she served as a business advisor in drug delivery innovation and integrated care models to senior management and board of directors at early-stage companies, biopharma and medtech companies, non-profit organizations, and investment firms. She was previously involved as Managing Director and Partner at Health Advances where she created and led the diabetes and drug delivery consulting practice for 15+ years. In addition, Marie has been integrally involved with the T1D Exchange, an initiative funded by The Helmsley Charitable Trust focused on accelerating outcomes for people with type 1 diabetes. Marie has a Bachelor of Arts degree in Chemistry from the University of Vermont. On a personal note, she is committed to bringing better solutions to people with diabetes and chronic diseases motivated in part by her personal 33-year history with type 1 diabetes.
Programming descriptions are generated by participants and do not necessarily reflect the opinions of SXSW.